Build a structured research protocol by selecting compounds, setting dosing schedules, and adding cycle details. Export as a formatted PDF for your research records.
Research purposes only. This tool is for licensed researchers. These compounds are not FDA-approved for human use and do not constitute medical advice.
No compounds added yet
Click "Add Compound" to start building your protocol.
• Recovery peptides (BPC-157, TB-500) are often stacked for synergistic tissue repair effects.
• GH axis peptides (CJC-1295 + Ipamorelin) are commonly combined — GHRH + GHRP produces synergistic GH release.
• Cycle duration varies by compound: short-acting peptides (Ipamorelin, BPC-157) are typically run 8–12 weeks; longer-acting (CJC-1295 w/ DAC) may run 12–16 weeks.
• Click any compound name to view its full research profile, including mechanism, evidence database, and pharmacokinetics.
Medical Disclaimer: All content on this site is for educational and research purposes only. Research peptides are not FDA-approved for human use. Always consult a qualified healthcare professional before considering any peptide or supplement protocol. Nothing on this site constitutes medical advice, diagnosis, or treatment.